Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
This time, the activity dropped and recovered as expected, but to a new, lower baseline set by ketamine ... However, until now, it wasn't fully understood how the drug produced its antidepressant ...